Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells.
about
Antibody-based immunotherapy of solid cancers: progress and possibilitiesMyeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor MicroenvironmentRegulation of immune responses by prostaglandin E2E-type prostanoid receptor 4 (EP4) in disease and therapyA review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methodsRegulatory myeloid cells in transplantationUpdate on the challenges and recent advances in cancer immunotherapyImproving cancer immunotherapy by targeting the STATe of MDSCsPhenotype, development, and biological function of myeloid-derived suppressor cellsSignal transducer and activator of transcription 3 in myeloid-derived suppressor cells: an opportunity for cancer therapyImmunosuppression associated with chronic inflammation in the tumor microenvironmentCerebral ischemia increases bone marrow CD4+CD25+FoxP3+ regulatory T cells in mice via signals from sympathetic nervous systemImmune heterogeneity in neuroinflammation: dendritic cells in the brainTherapeutic cancer vaccines and combination immunotherapies involving vaccinationMyeloid-derived suppressor cells: the dark knight or the joker in viral infections?Evaluation of the therapeutic potential of bone marrow-derived myeloid suppressor cell (MDSC) adoptive transfer in mouse models of autoimmunity and allograft rejection.Myeloid Cell COX-2 deletion reduces mammary tumor growth through enhanced cytotoxic T-lymphocyte functionGenetic variation in prostaglandin synthesis and related pathways, NSAID use and colorectal cancer risk in the Colon Cancer Family RegistryBig opportunities for small molecules in immuno-oncology.Synovial fluid myeloid dendritic cells display important differences compared to monocyte-derived dendritic cells prepared in vitroChronic psychological stress induces the accumulation of myeloid-derived suppressor cells in mice.Differential adjuvant activities of TLR7 and TLR9 agonists inversely correlate with nitric oxide and PGE2 productionMPGES-1-derived PGE2 suppresses CD80 expression on tumor-associated phagocytes to inhibit anti-tumor immune responses in breast cancer.Prostaglandin E2 and programmed cell death 1 signaling coordinately impair CTL function and survival during chronic viral infection.Finasteride Enhances the Generation of Human Myeloid-Derived Suppressor Cells by Up-Regulating the COX2/PGE2 PathwayCOX-2 promotes metastasis in nasopharyngeal carcinoma by mediating interactions between cancer cells and myeloid-derived suppressor cells.Anticancer activity of MPT0G157, a derivative of indolylbenzenesulfonamide, inhibits tumor growth and angiogenesisAspirin, nonaspirin nonsteroidal anti-inflammatory drugs, or acetaminophen and risk of ovarian cancerFunctional expression cloning identifies COX-2 as a suppressor of antigen-specific cancer immunityActivated cytotoxic lymphocytes promote tumor progression by increasing the ability of 3LL tumor cells to mediate MDSC chemoattraction via Fas signaling.Transcriptional regulation of myeloid-derived suppressor cells.Intragraft CD11b(+) IDO(+) cells mediate cardiac allograft tolerance by ECDI-fixed donor splenocyte infusionsGrowth and adherence of Staphylococcus aureus were enhanced through the PGE2 produced by the activated COX-2/PGE2 pathway of infected oral epithelial cells.mTOR masters monocytic myeloid-derived suppressor cells in mice with allografts or tumorsObesity-driven inflammation and cancer risk: role of myeloid derived suppressor cells and alternately activated macrophages.Alternative approaches to myeloid suppressor cell therapy in transplantation: comparing regulatory macrophages to tolerogenic DCs and MDSCs.Manifestations of immune tolerance in the human female reproductive tract.An inflammatory mediator, prostaglandin E2, in colorectal cancer.Microenvironment generated during EGFR targeted killing of pancreatic tumor cells by ATC inhibits myeloid-derived suppressor cells through COX2 and PGE2 dependent pathway.Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans
P2860
Q26796542-360CC3DB-F854-44F6-A95B-D02626F863E8Q26799126-5C370920-5312-4306-9E26-4DADA95CF30BQ26849305-26AB4174-02E7-4264-8F91-2A1DF5BEC3B3Q26851156-A6137476-1E35-4965-8B10-8E28053278B6Q26998969-DCE491B4-C1AD-4356-9073-773E214D33B7Q26999875-AF2EA7F6-E852-4A72-8B7C-2345447CD467Q27014693-EDE01A64-169F-4C1E-AE98-08F1D56775E2Q28066797-E4000B06-91BE-4DC7-A9A5-10F58C47D64EQ28079046-716B4A24-0DAC-406D-A2B4-345D7A160081Q28080262-81C28513-35A0-4023-B8D9-000FB3F1B910Q28083450-470978A1-ADCC-46A6-8A57-BCC907A151C4Q28245649-362A0544-FAD6-4423-9B62-5CD0A8554B8AQ28385127-EAB14FF0-2BD6-4272-9913-250414698019Q28397609-0D4EB780-5AD3-4B9A-B785-7FEAB6307403Q30411008-31686F2A-E8D8-4F90-A799-EA66DBB47D14Q33754157-6E3E4015-EC93-49F8-B6AA-4C4355177CEEQ34009960-295783E6-AFBC-4436-9450-F0FD54997B01Q34096843-5293AC10-FA4A-4583-BDB8-D429AF5A292DQ34487689-FDBBF72E-78F8-43C9-9C6D-09E6F7136E81Q34511662-6FA1B040-C3ED-4348-8F40-29F9E229FECFQ34994724-03F230C3-DBBA-43E2-A54C-E8162ABF0EBCQ35392417-09ACA027-DDDF-421A-96B1-BE43D23B760CQ35832981-8A085D74-C4E7-475F-B6CC-366226041164Q35861089-47C1C0FB-1B59-45C3-9A44-93FBB8077FC3Q36037921-1DCEC441-C684-4A65-9E80-1B67FD7A5976Q36110362-A5133D80-0432-4DD7-AB93-927F8D38DF84Q36210950-B40958CA-66EC-420C-9CB0-032309E114F5Q36266504-49E272C9-9D25-485E-AC1D-26B675579003Q36292012-3813CD03-A14E-4432-9C6E-9C9A606461EFQ36302820-0F2022B2-9611-4718-B1AD-9C84C4D82D0DQ36322351-94040CF5-165F-4AA6-8FEC-AC072B4C20B6Q36356879-DF27717D-7C68-499E-9AC4-562E57D02639Q36363166-0D217518-0A02-4F0D-B7A2-4B5DA34FAA20Q36527132-CED49768-82E8-4178-94E0-ED80BDBB4088Q36562906-708E78FA-7712-4395-AFDB-8AACDCF6EE57Q36578322-184B81BE-BBF6-4AAE-B3EB-2E85DA56058AQ36606027-01F9E5E4-C13B-4FA8-B695-CFE783679283Q36701908-A1EA727C-06E9-4A0D-84F3-42132949B96FQ36718698-A9874DF1-B485-48DB-AB36-5ADD7E0C08F8Q36761567-F722ACAE-ED85-4423-8C22-5493BBF2AAFE
P2860
Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Positive feedback between PGE2 ...... loid-derived suppressor cells.
@ast
Positive feedback between PGE2 ...... loid-derived suppressor cells.
@en
type
label
Positive feedback between PGE2 ...... loid-derived suppressor cells.
@ast
Positive feedback between PGE2 ...... loid-derived suppressor cells.
@en
prefLabel
Positive feedback between PGE2 ...... loid-derived suppressor cells.
@ast
Positive feedback between PGE2 ...... loid-derived suppressor cells.
@en
P2093
P2860
P1433
P1476
Positive feedback between PGE2 ...... eloid-derived suppressor cells
@en
P2093
Jamie Lesnock
Natasa Obermajer
Pawel Kalinski
Robert P Edwards
P2860
P304
P356
10.1182/BLOOD-2011-07-365825
P407
P577
2011-10-04T00:00:00Z